{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:51Z","timestamp":1787009871420,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To identify the impact of clindamycin use on mortality and amputation rates in patients with necrotizing fasciitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Level 1 trauma center, single-center study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients\/Participants:<\/jats:title>\n                    <jats:p>All patients from 2008 to 2019 with a diagnosis of necrotizing fasciitis. One hundred ninety patients were included in statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention:<\/jats:title>\n                    <jats:p>Use of clindamycin in the initial antibiotic regimen in the treatment of necrotizing soft tissue infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measurements:<\/jats:title>\n                    <jats:p>Amputation and mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients who received clindamycin had 2.92 times reduced odds of having an amputation when compared with their counterparts, even when American Society of Anesthesiologist scores, comorbidities, smoking, drug use, alcohol consumption, race, ethnicity, sex, and age were controlled for and regardless of other antibiotics started (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015). There was no significant difference in mortality rate between those patients who did and did not receive clindamycin as part of their initial antibiotic regimen (8.3% vs. 11.6%, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.453).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The use of clindamycin in the initial antibiotic regimen for treatment of NSTI was shown to significantly decrease rates of amputation but not mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000002324","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T01:26:08Z","timestamp":1638840368000},"page":"327-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Use of Clindamycin for Necrotizing Soft Tissue Infection Decreases Amputation Rate"],"prefix":"10.1097","volume":"36","author":[{"given":"David M.","family":"Heath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden J.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah N.","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Momtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina I.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S095026880500484X","article-title":"Cellulitis incidence in a defined population","volume":"134","author":"Ellis Simonsen","year":"2006","journal-title":"Epidemiol Infect."},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13017-019-0286-6","article-title":"Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis","volume":"15","author":"Nawijn","year":"2020","journal-title":"World J Emerg Surg."},{"key":"R3-20250614","first-page":"312","article-title":"Nekrotisierende fasziitis","volume":"53","author":"Jansen-Winkeln","year":"2020","journal-title":"Der Chir."},{"key":"R4-20250614","first-page":"269","article-title":"Clindamycin affects group A Streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis."},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.hcl.2020.03.007","article-title":"Necrotizing soft tissue infections of the upper extremity","volume":"36","author":"Melillo","year":"2020","journal-title":"Hand Clin."},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"e4592","DOI":"10.1093\/cid\/ciaa976","article-title":"Outcomes of \u03b2-hemolytic streptococcal necrotizing skin and soft-tissue infections and the impact of clindamycin resistance","volume":"73","author":"Horn","year":"2020","journal-title":"Clin Infect Dis."},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/TA.0000000000002636","article-title":"Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections","volume":"89","author":"Horn","year":"2020","journal-title":"J Trauma Acute Care Surg."},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13017-018-0207-0","article-title":"Risk factors for mortality in the late amputation of necrotizing fasciitis: a retrospective study","volume":"13","author":"Chang","year":"2018","journal-title":"World J Emerg Surg."},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13018-019-1108-y","article-title":"Lactate on emergency department arrival as a predictor of in-hospital mortality in necrotizing fasciitis: a retrospective study","volume":"14","author":"Chang","year":"2019","journal-title":"J Orthop Surg Res."},{"key":"R10-20250614","first-page":"27","article-title":"Predicting morbidity and mortality in patients with lower extremity necrotizing fasciitis","volume":"53","author":"\u0130rmak","year":"2019","journal-title":"Sisli Etfal Hastan Tip Bul."},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/bjd.15615","article-title":"Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007\u20132012","volume":"177","author":"Audureau","year":"2017","journal-title":"Br J Dermatol."},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00268-019-05256-9","article-title":"Factors associated with mortality and amputation caused by necrotizing soft tissue infections of the upper extremity: a retrospective cohort study","volume":"44","author":"Nawijn","year":"2020","journal-title":"World J Surg."},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/jcm7110435","article-title":"Diagnostic performance of initial serum albumin level for predicting in-hospital mortality among necrotizing fasciitis patients","volume":"7","author":"Chang","year":"2018","journal-title":"J Clin Med."},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/sur.2019.277","article-title":"Mortality risk in necrotizing fasciitis: national prevalence, trend, and burden","volume":"21","author":"Al-Qurayshi","year":"2020","journal-title":"Surg Infect (Larchmt)."},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1302\/0301-620X.96B11.34888","article-title":"Necrotising soft-tissue infections of the upper limb: risk factors for amputation and death","volume":"96B","author":"Uehara","year":"2014","journal-title":"Bone Joint J."},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/000313481307901030","article-title":"Predictors of mortality and limb loss in necrotizing soft tissue infections","volume":"79","author":"Schwartz","year":"2013","journal-title":"Am Surg."},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/CORR.0000000000001187","article-title":"What demographic and clinical factors are associated with in-hospital mortality in patients with necrotizing fasciitis?","volume":"478","author":"Karnuta","year":"2020","journal-title":"Clin Orthop Relat Res."},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2015.08.054","article-title":"Prognostic factors in necrotizing soft-tissue infections (NSTI): a cohort study","volume":"73","author":"Hua","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/14787210.3.2.279","article-title":"Necrotizing fasciitis: pathogenesis and treatment","volume":"3","author":"Young","year":"2005","journal-title":"Expert Rev Anti Infect Ther."},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-57616-5_10","article-title":"Systems genetics approaches in mouse models of group A streptococcal necrotizing soft-tissue infections","volume":"1294","author":"Nookala","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","article-title":"Necrotizing skin and soft-tissue infections in the intensive care unit","volume":"26","author":"Peetermans","year":"2020","journal-title":"Clin Microbiol Infect."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T15:02:07Z","timestamp":1749913327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002324","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"2021-11-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}